Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo

References

• Barenholz Y. (2012). Doxil®-the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–34.
   PubMed Web of Science ®Google Scholar
• Bush N, Healey A, Shah A, et al. (2020). Theranostic attributes of acoustic cluster therapy and its use for enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice. Front Pharmacol 11:75.
   PubMed Web of Science ®Google Scholar
• Chabner BA, Roberts TG. (2005). Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72.
   PubMed Web of Science ®Google Scholar
• Chidambaram M, Manavalan R, Kathiresan K. (2011). Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 14:67–77.
   PubMed Web of Science ®Google Scholar
• Danhier F. (2016). To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release 244:108–21.
   PubMed Web of Science ®Google Scholar
• De Jong N, Frinking PJA, Bouakaz A, et al. (2000). Optical imaging of contrast agent microbubbles in an ultrasound field with a 100-MHz camera. Ultrasound Med Biol 26:487–92.
   PubMed Web of Science ®Google Scholar
• Egawa G, Nakamizo S, Natsuaki Y, et al. (2013). Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep 3:1932.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. (2011). The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51.
   PubMed Web of Science ®Google Scholar
• Fujishiro S, Mitsumori M, Nishimura Y, et al. (1998). Increased heating efficiency of hyperthermia using an ultrasound contrast agent: a phantom study. Int J Hyperthermia 14:495–502.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Catane R, Uziely B, et al. (1994). Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987–92.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. (2003). Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419–36.
   PubMed Web of Science ®Google Scholar
• Gabizon AA, Barenholz Y, Bialer M. (1993). Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res 10:703–8.
   PubMed Web of Science ®Google Scholar
• Golombek SK, May J-N, Theek B, et al. (2018). Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38.
   PubMed Web of Science ®Google Scholar
• Hofmann M, McCormack E, Mujic M, et al. (2009). Increased plasma colloid osmotic pressure facilitates the uptake of therapeutic macromolecules in a xenograft tumor model. Neoplasia 11:812–22.
   PubMed Web of Science ®Google Scholar
• Hori K, Suzuki M, Tanda S, et al. (1991). Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension. Jpn J Cancer Res 82:1309–16.
   PubMedGoogle Scholar
• Kondo T, Umemura S, Tanabe K, et al. (2000). Novel therapeutic applications of ultrasound utilization of thermal and cavitational effects. Jpn J Hyperthermic Oncol 16:203–16.
   Google Scholar
• Kotopoulis S, Stigen E, Popa M, et al. (2017). Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcinoma. J Control Release 245:70–80.
   PubMed Web of Science ®Google Scholar
• Kudo N, Okada K, Yamamoto K. (2009). Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J 96:4866–76.
   PubMed Web of Science ®Google Scholar
• Lu CT, Zhao Y-Z, Wu Y, et al. (2011). Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol 68:343–8.
   PubMed Web of Science ®Google Scholar
• Maeda H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207.
   PubMedGoogle Scholar
• Martin KH, Dayton PA. (2013). Current status and prospects for microbubbles in ultrasound theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:329–45.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92.
   PubMed Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. (2006). Drug penetration in solid tumours. Nat Rev Cancer 6:583–92.
   PubMed Web of Science ®Google Scholar
• Ogawara K, Un K, Tanaka K, et al. (2009). In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: involvement of cytotoxic effect on vascular endothelial cells. J Control Release 133:4–10.
   PubMed Web of Science ®Google Scholar
• Omata D, Maruyama T, Unga J, et al. (2019). Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery. J Control Release 311–312:65–73.
   PubMed Web of Science ®Google Scholar
• Paefgen V, Doleschel D, Kiessling F. (2015). Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol 6:197.
   PubMed Web of Science ®Google Scholar
• Petersen GH, Alzghari SK, Chee W, et al. (2016). Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J Control Release 232:255–64.
   PubMed Web of Science ®Google Scholar
• Shimizu R, Suzuki R. Kudo N. (2020). Visualization of endothelial cell damage caused by ultrasonically induced microbubble oscillation inside a capillary phantom. Paper presented at the 2020 IEEE International Ultrasonics Symposium (IUS); September 7–11; Las Vegas, NV.
   Google Scholar
• Soloman R, Gabizon AA. (2008). Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin. Clin Lymphoma Myeloma 8:21–32.
   PubMedGoogle Scholar
• Sonoda S, Tachibana K, Uchino E, et al. (2007). Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 6:1276–83.
   PubMed Web of Science ®Google Scholar
• Sorace AG, Warram JM, Umphrey H, Hoyt K. (2012). Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 20:43–54.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Oda Y, Omata D, et al. (2016). Tumor growth suppression by the combination of nanobubbles and ultrasound. Cancer Sci 107:217–23.
   PubMed Web of Science ®Google Scholar
• Taurin S, Nehoff H, Greish K. (2012). Anticancer nanomedicine and tumor vascular permeability; where is the missing link? J Control Release 164:265–75.
   PubMed Web of Science ®Google Scholar
• Ueno Y, Sonoda S, Suzuki R, et al. (2011). Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth. Cancer Biol Ther 12:270–7.
   PubMed Web of Science ®Google Scholar
• Unga J, Kageyama S, Suzuki R, et al. (2020). Scale-up production, characterization and toxicity of a freeze-dried lipid-stabilized microbubble formulation for ultrasound imaging and therapy. J Liposome Res 30:297–304.
   PubMed Web of Science ®Google Scholar
• Unga J, Omata D, Kudo N, et al. (2019). Development and evaluation of stability and ultrasound response of DSPC-DPSG-based freeze-dried microbubbles. J Liposome Res 29:368–74.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Aoi A, Horie S, et al. (2008). Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 99:2525–31.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, et al. (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol 3:487–97.
   PubMed Web of Science ®Google Scholar
• Yokoe I, Murahata Y, Harada K, et al. (2020). A pilot study on efficacy of lipid bubbles for theranostics in dogs with tumors. Cancers 12:2423.
   PubMed Web of Science ®Google Scholar
• Yuan F, Leunig M, Huang SK, et al. (1994). Mirovascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352–6.
   PubMed Web of Science ®Google Scholar
• Zhu F, Jiang Y, Luo F, Li P. (2015). Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model. J Drug Target 23:323–34.
   PubMed Web of Science ®Google Scholar